| Literature DB >> 31872085 |
Stephen F Kry1,2, Christine B Peterson3, Rebecca M Howell2,4, Joanna Izewska5, Jessica Lye6, Catharine H Clark7,8,9, Mitsuhiro Nakamura10, Coen Hurkmans11,12, Paola Alvarez1,2, Andrew Alves6, Tomislav Bokulic5, David Followill1,2, Pavel Kazantsev5, Jessica Lowenstein1,2, Andrea Molineu1,2, Jacob Palmer2,4, Susan A Smith2,4, Paige Taylor1,2, Paulina Wesolowska5, Ivan Williams6.
Abstract
BACKGROUND ANDEntities:
Keywords: Global harmonization group; QA; calibration; dosimetry audit; remote beam output audit
Year: 2018 PMID: 31872085 PMCID: PMC6927685 DOI: 10.1016/j.phro.2018.08.005
Source DB: PubMed Journal: Phys Imaging Radiat Oncol ISSN: 2405-6316
Methods for conducting remote beam output audits. Details of the dosimeter and dosimetry programme are shown for each QA group in the GHG that performs remote beam output audits.
| QA Group | Dosimeter | Frequency | Mandatory audit? | Primary recipients | Uncertainty (%) (k = 1) | Tolerance (±%) | Beams per year (ave) | Key ref(s) |
|---|---|---|---|---|---|---|---|---|
| ACDS | nanoDot OSLD | Every other year | Yes | Australian facilities | Electrons:1.7 | Electrons: 5.1 | 392 | |
| EORTC | Various | When joining a trial if last audit >2 years prior | Yes | European clinical trial participants | Varies-not always known by EORTC | 5 | 356 | |
| IAEA | TLD-100 | By request | No | Facilities in low/middle income countries | 60Co: 1.5 | 5 | 623 | |
| IROC | nanoDot OSLD | Annual | Yes | North American clinical trial participants | 1.7 | 5 | 16,680 | |
| JCOG | Glass RPLD | Every 3 years | Yes | Japanese facilities | 1.1 | 5 | ∼500 | |
| RDS | TLD-100 | By request | No | North American facilities | 1.3 | 5 | 11,775 |
Abbreviations: ACDS: Australian Clinical Dosimetry Services; EORTC: European Organisation for Research and Treatment of Cancer; IAEA: International Atomic Energy Agency; IROC: Imaging and Radiation Oncology Core; JCOG: Japan Clinical Oncology Group; ANTM: Association for Nuclear Technology in Medicine; RDS: Radiation Dosimetry Services; OSLD: optically stimulated luminescence dosimeter; TLD: thermoluminescent dosimeter; RPLD: radiophotoluminescent dosimeter.
Beam output audit results evaluated in this study.
Measurements of the reference output dose for JCOG trials are performed by ANTM for designated cancer centers.
Fig. 1Percentage of remote beam output audit results outside the ±5% tolerance. The IAEA reported the highest percentage while the ACDS reported the lowest. Electron beam results were more likely to be outside of tolerance than photon beams.
Fig. 2Percent of remote beam output audit results outside the ±5% tolerance as a function of audit year. The blue line is the fitted regression line and the grey areas represent the 95% confidence intervals. The grey area is larger for the IAEA results because of the smaller number of results. Audit results have shown significant improvement with time. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 3Percent of remote beam output audit results outside the ±5% tolerance as a function of beam energy (MV for X-rays, MeV for electrons). The blue dot is the most common energy (6 MV and 12 MeV) against which other energies were compared. Orange dots are those significantly different from the most common. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 4Primary cause of confirmed calibration errors.